Cargando…

Insight into Genetic Characteristics of Identified SARS-CoV-2 Variants in Egypt from March 2020 to May 2021

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was first detected in Egypt in February 2020. Data about the prevalence rates of the SARS-CoV-2 lineages are relatively scarce. To understand the genetic characteristics of SARS-CoV-2 in Egypt during several waves of the pandemic, we analy...

Descripción completa

Detalles Bibliográficos
Autores principales: Roshdy, Wael H., Kandeil, Ahmed, El-Shesheny, Rabeh, Khalifa, Mohamed K., Al-Karmalawy, Ahmed A., Showky, Shymaa, Naguib, Amel, Elguindy, Nancy, Fahim, Manal, Abu Elsood, Hanaa, El Taweel, Ahmed, Salamony, Azza, Mohsen, Amira, Kayali, Ghazi, Ali, Mohamed A., Kandeel, Amr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330621/
https://www.ncbi.nlm.nih.gov/pubmed/35894057
http://dx.doi.org/10.3390/pathogens11080834
_version_ 1784758207131942912
author Roshdy, Wael H.
Kandeil, Ahmed
El-Shesheny, Rabeh
Khalifa, Mohamed K.
Al-Karmalawy, Ahmed A.
Showky, Shymaa
Naguib, Amel
Elguindy, Nancy
Fahim, Manal
Abu Elsood, Hanaa
El Taweel, Ahmed
Salamony, Azza
Mohsen, Amira
Kayali, Ghazi
Ali, Mohamed A.
Kandeel, Amr
author_facet Roshdy, Wael H.
Kandeil, Ahmed
El-Shesheny, Rabeh
Khalifa, Mohamed K.
Al-Karmalawy, Ahmed A.
Showky, Shymaa
Naguib, Amel
Elguindy, Nancy
Fahim, Manal
Abu Elsood, Hanaa
El Taweel, Ahmed
Salamony, Azza
Mohsen, Amira
Kayali, Ghazi
Ali, Mohamed A.
Kandeel, Amr
author_sort Roshdy, Wael H.
collection PubMed
description Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was first detected in Egypt in February 2020. Data about the prevalence rates of the SARS-CoV-2 lineages are relatively scarce. To understand the genetic characteristics of SARS-CoV-2 in Egypt during several waves of the pandemic, we analyzed sequences of 1256 Egyptian SARS-CoV-2 full genomes from March 2020 to May 2021. From one wave to the next, dominant strains have been observed to be replaced by other dominant strains. We detected an emerging lineage of SARS-CoV-2 in Egypt that shares mutations with the variant of concern (VOC). The neutralizing capacity of sera collected from cases infected with C.36.3 against dominant strains detected in Egypt showed a higher cross reactivity of sera with C.36.3 compared to other strains. Using in silico tools, mutations in the spike of SARS-CoV-2 induced a difference in binding affinity to the viral receptor. The C.36 lineage is the most dominant SARS-CoV-2 lineage in Egypt, and the heterotrophic antigenicity of SARS-CoV-2 variants is asymmetric. These results highlight the value of genetic and antigenic analyses of circulating strains in regions where published sequences are limited.
format Online
Article
Text
id pubmed-9330621
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93306212022-07-29 Insight into Genetic Characteristics of Identified SARS-CoV-2 Variants in Egypt from March 2020 to May 2021 Roshdy, Wael H. Kandeil, Ahmed El-Shesheny, Rabeh Khalifa, Mohamed K. Al-Karmalawy, Ahmed A. Showky, Shymaa Naguib, Amel Elguindy, Nancy Fahim, Manal Abu Elsood, Hanaa El Taweel, Ahmed Salamony, Azza Mohsen, Amira Kayali, Ghazi Ali, Mohamed A. Kandeel, Amr Pathogens Article Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was first detected in Egypt in February 2020. Data about the prevalence rates of the SARS-CoV-2 lineages are relatively scarce. To understand the genetic characteristics of SARS-CoV-2 in Egypt during several waves of the pandemic, we analyzed sequences of 1256 Egyptian SARS-CoV-2 full genomes from March 2020 to May 2021. From one wave to the next, dominant strains have been observed to be replaced by other dominant strains. We detected an emerging lineage of SARS-CoV-2 in Egypt that shares mutations with the variant of concern (VOC). The neutralizing capacity of sera collected from cases infected with C.36.3 against dominant strains detected in Egypt showed a higher cross reactivity of sera with C.36.3 compared to other strains. Using in silico tools, mutations in the spike of SARS-CoV-2 induced a difference in binding affinity to the viral receptor. The C.36 lineage is the most dominant SARS-CoV-2 lineage in Egypt, and the heterotrophic antigenicity of SARS-CoV-2 variants is asymmetric. These results highlight the value of genetic and antigenic analyses of circulating strains in regions where published sequences are limited. MDPI 2022-07-26 /pmc/articles/PMC9330621/ /pubmed/35894057 http://dx.doi.org/10.3390/pathogens11080834 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Roshdy, Wael H.
Kandeil, Ahmed
El-Shesheny, Rabeh
Khalifa, Mohamed K.
Al-Karmalawy, Ahmed A.
Showky, Shymaa
Naguib, Amel
Elguindy, Nancy
Fahim, Manal
Abu Elsood, Hanaa
El Taweel, Ahmed
Salamony, Azza
Mohsen, Amira
Kayali, Ghazi
Ali, Mohamed A.
Kandeel, Amr
Insight into Genetic Characteristics of Identified SARS-CoV-2 Variants in Egypt from March 2020 to May 2021
title Insight into Genetic Characteristics of Identified SARS-CoV-2 Variants in Egypt from March 2020 to May 2021
title_full Insight into Genetic Characteristics of Identified SARS-CoV-2 Variants in Egypt from March 2020 to May 2021
title_fullStr Insight into Genetic Characteristics of Identified SARS-CoV-2 Variants in Egypt from March 2020 to May 2021
title_full_unstemmed Insight into Genetic Characteristics of Identified SARS-CoV-2 Variants in Egypt from March 2020 to May 2021
title_short Insight into Genetic Characteristics of Identified SARS-CoV-2 Variants in Egypt from March 2020 to May 2021
title_sort insight into genetic characteristics of identified sars-cov-2 variants in egypt from march 2020 to may 2021
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330621/
https://www.ncbi.nlm.nih.gov/pubmed/35894057
http://dx.doi.org/10.3390/pathogens11080834
work_keys_str_mv AT roshdywaelh insightintogeneticcharacteristicsofidentifiedsarscov2variantsinegyptfrommarch2020tomay2021
AT kandeilahmed insightintogeneticcharacteristicsofidentifiedsarscov2variantsinegyptfrommarch2020tomay2021
AT elsheshenyrabeh insightintogeneticcharacteristicsofidentifiedsarscov2variantsinegyptfrommarch2020tomay2021
AT khalifamohamedk insightintogeneticcharacteristicsofidentifiedsarscov2variantsinegyptfrommarch2020tomay2021
AT alkarmalawyahmeda insightintogeneticcharacteristicsofidentifiedsarscov2variantsinegyptfrommarch2020tomay2021
AT showkyshymaa insightintogeneticcharacteristicsofidentifiedsarscov2variantsinegyptfrommarch2020tomay2021
AT naguibamel insightintogeneticcharacteristicsofidentifiedsarscov2variantsinegyptfrommarch2020tomay2021
AT elguindynancy insightintogeneticcharacteristicsofidentifiedsarscov2variantsinegyptfrommarch2020tomay2021
AT fahimmanal insightintogeneticcharacteristicsofidentifiedsarscov2variantsinegyptfrommarch2020tomay2021
AT abuelsoodhanaa insightintogeneticcharacteristicsofidentifiedsarscov2variantsinegyptfrommarch2020tomay2021
AT eltaweelahmed insightintogeneticcharacteristicsofidentifiedsarscov2variantsinegyptfrommarch2020tomay2021
AT salamonyazza insightintogeneticcharacteristicsofidentifiedsarscov2variantsinegyptfrommarch2020tomay2021
AT mohsenamira insightintogeneticcharacteristicsofidentifiedsarscov2variantsinegyptfrommarch2020tomay2021
AT kayalighazi insightintogeneticcharacteristicsofidentifiedsarscov2variantsinegyptfrommarch2020tomay2021
AT alimohameda insightintogeneticcharacteristicsofidentifiedsarscov2variantsinegyptfrommarch2020tomay2021
AT kandeelamr insightintogeneticcharacteristicsofidentifiedsarscov2variantsinegyptfrommarch2020tomay2021